Research
He is leading an international genotyping/ phenotyping collaboration in chronic thromboembolic pulmonary hypertension and has close ties to the Pulmonary Vascular Diseases Unit in Royal Papworth Hospital. His research group is focused on preclinical target identification and early phase trials in pulmonary vascular diseases.

The major themes of the group are-
Genetic susceptibility to pulmonary hypertension
The pathobiology of chronic thromboembolic pulmonary hypertension
Novel early phase drug development in pulmonary hypertension